Acne Treatment Preferences and Pharmaceutical Care Patterns in Georgian Pharmacies

Acne vulgaris is a global problem that requires a challenging and prolonged treatment course for patients (1,2). It significantly impacts a patient’s quality of life, affecting self-esteem and other psychosocial factors. Patients encounter many over-the-counter and prescription acne treatments, including topical creams, gels, cleansers, antibiotics, retinoids, and hormonal therapies. The variety of options can be overwhelming, and the lack of clear, personalized guidance on choosing between these therapies adds to the confusion. Exploring patients’ behaviors, preferences, and reliance on healthcare professionals is essential for improving acne management strategies and ensuring the effectiveness of the treatment. Aim: The study aimed to explore the treatment behaviors, preferences, and decision-making processes of acne vulgaris patients in Georgia, focusing on their use of dermatological and cosmeceutical products, medications such as antibiotics, retinoids, and hormone therapies, and their reliance on healthcare professionals. Method: A structured online questionnaire was distributed to a targeted group on social networks (“Acne,” “Skin Health”). Survey respondents had to have been affected by acne at least once in their lifetime. Key Findings and Conclusions: 200 respondents participated in the survey, with more than half experiencing acne from adolescence to adulthood. Among them, around 70% had moderate to severe acne, yet only half consulted a specialist. When selecting treatment, respondents equally valued advice from pharmacists and doctors, followed by recommendations from acquaintances and online information. of those treated by doctors, 26.1% received antibiotics, 11.6% used oral retinoids, and nearly 19.5% underwent hormone therapy. Retinoids were prescribed by pharmacists in 6% of cases, and 18.6% self-medicated. Popular acne treatment brands in Georgia included SVR, La-Roche-Posay, and Bioderma, with most consumers keeping track of new product releases.